Among female sex workers living with HIV in the Dominican Republic, greater mindfulness was linked to lower depression and HIV stigma, and higher antiretroviral therapy adherence both at the same time and at later time points. Higher mindfulness also showed contemporaneous associations with reduced at-risk alcohol use and higher viral suppression. The findings suggest that mindfulness instruction could help improve mental health and HIV outcomes in this population.
From 2021 to 2023, overall hallucinogen use among Americans aged 12 and older remained stable at about 2.8%, but trends for individual substances diverged. LSD use declined from 0.88% to 0.58%, while ketamine use increased from 1.61% to 1.91%. Use of ecstasy/MDMA and tryptamines (including DMT) stayed steady, and PCP and Salvia divinorum remained rare. Hallucinogen use was concentrated among young adults and males, with higher odds among uninsured individuals and those below the federal poverty level. Substance-specific monitoring may better inform screening, prevention, and harm-reduction efforts than aggregate hallucinogen indicators.